Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TCM Biotech International Corp. (4169) Financial Statements

TCM Biotech International Corp. Financial Overview

TCM Biotech International Corp.'s market cap is currently NT$7.93B. The company's EPS TTM is NT$-0.40; its P/E ratio is -291.25; and it has a dividend yield of 0.27%. TCM Biotech International Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 685.49MNT$ 666.53MNT$ 969.62MNT$ 802.42MNT$ 702.05M
Gross ProfitNT$ 296.68MNT$ 327.31MNT$ 480.17MNT$ 448.49MNT$ 358.72M
Operating IncomeNT$ 18.65MNT$ 10.01MNT$ 22.33MNT$ 25.30MNT$ 2.13M
EBITDANT$ 42.18MNT$ 50.49MNT$ 46.70MNT$ 45.51MNT$ 22.28M
Net IncomeNT$ 19.17MNT$ 21.01MNT$ 18.57MNT$ 18.27MNT$ 1.87M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 545.07MNT$ 532.98MNT$ 504.13MNT$ 89.94MNT$ 58.26M
Total AssetsNT$ 1.20BNT$ 1.18BNT$ 1.32BNT$ 862.87MNT$ 820.06M
Total DebtNT$ 42.92MNT$ 51.04MNT$ 123.47MNT$ 171.14MNT$ 165.89M
Net DebtNT$ -202.15MNT$ -181.95MNT$ -380.66MNT$ 81.29MNT$ 107.63M
Total LiabilitiesNT$ 148.86MNT$ 123.28MNT$ 267.88MNT$ 326.20MNT$ 301.84M
Stockholders' EquityNT$ 1.06BNT$ 1.06BNT$ 1.06BNT$ 536.67MNT$ 518.22M
Cash Flow
Free Cash FlowNT$ 36.50MNT$ 159.07MNT$ -42.45MNT$ 46.95MNT$ 7.61M
Operating Cash FlowNT$ 38.99MNT$ 167.42MNT$ -37.54MNT$ 52.24MNT$ 15.33M
Investing Cash FlowNT$ 3.04MNT$ -340.40MNT$ -4.52MNT$ -8.09MNT$ -19.61M
Financing Cash FlowNT$ -29.90MNT$ -98.19MNT$ 456.30MNT$ -12.44MNT$ 28.24M

Currency in TWD

TCM Biotech International Corp. Earnings and Revenue History

0400M800M1.2B0 %2 %4 %6 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

TCM Biotech International Corp. Liabilities to Assets

0500M1B1.5B0 %15 %30 %45 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

TCM Biotech International Corp. Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

TCM Biotech International Corp. Forecast EPS vs Actual EPS

-0.7-0.5-0.200.30.50.8Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >